Transmission of drug resistant HIV and its potential impact on mortality and treatment outcomes in resource-limited settings.

Abstract excerpt

Scale-up of antiretroviral therapy in low- and middle-income countries has been achieved by using a public health approach that involved national standard regimens and clinical monitoring in settings where laboratory infrastructure was not available. This strategy potentially allows for long periods of unrecognized viral failure, during which drug-resistant virus can be transmitted and this could compromise the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Anti-Retroviral Agents
• Share to Cost-Benefit Analysis